The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Impact of Growth Hormone Supplementation on Adult Height in Turner Syndrome: Results of the Canadian Randomized Controlled Trial
Abstract
BACKGROUND: A randomized, controlled trial of GH supplementation to adult height in girls with short stature due to Turner syndrome was conducted in Canada. We report results in subjects who completed the protocol and subjects who participated in follow-up. METHODS: One hundred fifty-four girls with Turner syndrome, aged 7-13 yr, were randomly assigned to one of two groups: 1) GH by sc injection six times per week (0.30 mg/kg.wk), and 2) control (C), no GH treatment. Both cohorts received standardized sex steroid replacement starting at a chronological age of 13 yr. Subjects were followed until protocol completion, defined as height velocity less than 2 cm/yr and bone age 14 yr or greater. A subsequent protocol addendum requested follow-up safety and efficacy assessment in all patients at least 1 yr after the last core protocol visit. RESULTS: One hundred four patients completed the study (61 GH, 43 C), and 50 withdrew (15 GH, 35 C). At protocol completion, mean heights were 147.5 +/- 6.1 (GH) and 141.0 +/- 5.4 cm (C), respectively (P < 0.001). Of those who completed the protocol, 59 (40 GH, 19 C) had height data at least 1 yr after protocol completion; in that group, mean heights were 149.0 +/- 6.4 (GH) and 142.2 +/- 6.6 cm (C), respectively (P < 0.001). At protocol completion and follow-up, the mean height gain due to GH, estimated by analysis of covariance, was +7.2 cm (confidence interval 6.0, 8.4) and +7.3 cm (confidence interval 5.4, 9.2), respectively (both P < 0.001). CONCLUSIONS: This is the first evidence from a randomized, controlled trial to adult height that GH supplementation with induction of puberty at a near physiological age increases the adult height of girls with Turner syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite numerous studies of GH treatment in TS, only six randomized, controlled trials (RCTs) have compared GH treatment with a concurrent non-treatment or placebo control for at least one year157-162”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [158]
In the citing paper
“In the two clinical trials that maintained long-term untreated/placebo controls, adult height was within the normal range for 40%-50% of treated individuals vs. 4%-16% percent of non-GH treated individuals.158,160”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [158]
In the citing paper
“and only two of these trials have followed non-GH-treated participants to adult height.158,160”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [158]
In the citing paper
“after 2 years of treatment height velocity was ∼2 cm year−1 greater for treated than untreated girls in the study that continued the control arm long term.158”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [158]
In the citing paper
“a 2007 Cochrane Center review156 concluded that girls treated with GH grew 3 cm year−1 more than untreated girls in the first 12-18 months of therapy”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [158]
In the citing paper
“Younger age at treatment initiation,158,162,163 including at least 4 years of treatment prior to puberty,175,179,180 is associated with greater GH treatment effect.”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [158]
In the citing paper
“A subsequent meta-analysis concluded a similar effect of GH therapy, reporting mean adult height gain of 7.2 cm,168 based on data from the two RCTs that followed non-GH-treated subjects to adult height.158,160”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [158]
Citations
Cites
Physical growth: National Center for Health Statistics percentiles
Hamill, P. V. V., Drizd, T. A., Johnson, C., Reed, R. B., Roche, A., & Moore, W. (1979) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.3.607 · Cited by 2,322
Growth curve for girls with Turner syndrome.
Lyon, A., Preece, M. A., & Grant, D. B. (1985) · Archives of Disease in Childhood · doi:10.1136/adc.60.10.932 · Cited by 409
Tanner, J. M., Whitehouse, R. H., Hughes, P. C. R., & VINCE, F. P. (1971) · Archives of Disease in Childhood · doi:10.1136/adc.46.250.745 · Cited by 389
Growth hormone therapy of Turner's syndrome: beneficial effect on adult height
Rosenfeld, R. G., Attie, K. M., Frane, J., Brasel, A., Burstein, S., Cara, J. F., Chernausek, S., Gotlin, R. W., Kuntze, J., Lippe, B. M., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70452-4 · Cited by 265
van Pareren, Y. K., Keizer‐Schrama, S. M. P. F. D. M., Stijnen, T., Sas, T., Jansen, M., Otten, B. J., Hoorweg-Nijman, J. J. G., Vulsma, T., Stokvis‐Brantsma, W. H., Rouwé, C. W., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021171 · Cited by 244
Quigley, C. A., Crowe, B. J., Anglin, D. G., & Chipman, J. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8477 · Cited by 159
Psychosocial Development in Adolescents with Turner Syndrome
McCauley, E., Feuillan, P., Kushner, H., & ROSS, J. L. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200112000-00003 · Cited by 142
Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey
Gravholt, C. H., Vestergaard, P., Hermann, A. P., Mosekilde, L., Brixen, K., & Christiansen, J. S. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01807.x · Cited by 130
Four Decades of Growth Hormone Therapy for Short Children: What Have We Achieved?
Guyda, H. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6189 · Cited by 114
Rosenfeld, R. G., Hintz, R. L., Johanson, A. J., Brasel, J. A., Burstein, S., Chernausek, S. D., CLABOTS, T., Frane, J. W., Gotlin, R. W., Kuntze, J., et al. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80272-4 · Cited by 84
Flagged first, then by citations
Research works printed but not linked: 2
- Taback, 1995, Growth hormone, adult height, and psychosocial outcome in Turner syndrome: the need for controlled studies, In: Albertsson-Wikland K, Ranke MB, eds. Turner syndrome in a life-span perspective. Amsterdam: Elsevier Science B.V.;, 183
- 1998, Growth hormone treatment to final height in Turner syndrome: a randomized controlled trial, Horm Res, 50, 25
Cited by
Sorted by citations
Items 201–254 of 254
Gonadal dysgenesis: ovarian function and reproductive health in Turner syndrome
Saenger, P. H., & Rodriguez‐Buritica, D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.004
Klinisches Management des Ullrich-Turner-Syndroms
Schonhoff, P. (2011)
The Final Height of Turner’s Patients in Algeria
Haddam, A., Meskine, D., Chentli, F., & Fedala, N. S. (2015) · International Journal of Clinical Case Reports · doi:10.5376/ijccr.2015.05.0020
Growth and Growth-Promoting Therapy in Turner Syndrome
Sas, T., & Keizer‐Schrama, S. M. P. F. D. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1795-9_136
Ursu, H. I. (2008) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2008.471
Why we are Treating Children with Growth Hormone: Lessons from the French Registry
Carel, J., & Chaussain, J. (2005) · Springer eBooks · doi:10.1007/3-540-28902-x_12
Tratamiento de la talla baja con hormona de crecimiento: ¿los beneficios merecen la pena?
Allen, D. B. (2006) · PEDIATRICS
GUIDE - AFFECTION DE LONGUE DURÉE
de Turner, S. (2008)
Kleinwuchs – Differenzialdiagnose und therapeutische Optionen
Kapelari, K. (2015) · Journal für Klinische Endokrinologie und Stoffwechsel
Evidencias en el tratamiento con hormona del crecimiento. Nuevas indicaciones
García, E. G., Álvarez, J. L. M., Ibáñez, L., Irene, N., & Reyna, G. (2010)
Syndrome de Turner et désir de grossesse
Lesourd, F. (2009) · Springer eBooks · doi:10.1007/978-2-287-87855-8_10
Síndrome de Turner e diabetes mellitus – revisão da literatura a propósito de 4 casos
Simões‐Pereira, J., Bastos, M., Saraiva, J. C., Moreno, C., Dantas, R., Guelho, D., Vicente, N., Cardoso, L., Oliveira, D., Martins, D., et al. (2015) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.1016/j.rpedm.2015.09.004
Turner syndrome and growth hormone therapy: a review on growth response
Selveindran, N. M., Hong, J., Idris, A. N., Teoh, S., Leong, K. S. W., & Zain, F. M. (2015) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2015-s1-p37
Cardiovascular aspects in the diagnosis and management of Turner’s syndrome
Borg, A. N., Brabant, E. G., & Schmitt, M. (2014) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000020
Soomann, M., Peet, A., & Tillmann, V. (2015) · Ajakirjad. Journals by UT · doi:10.15157/ea.v0i0.12080
Emerging Aspects of Turner Syndrome
Gravholt, C. H., Stochholm, K., Cleemann, L. H., & Mortensen, K. H. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2011.07.01.58
Turner syndrome: Study of 42 cases
Bahillo-Curieses, P., Prieto‐Matos, P., González, R. Q., Santos, L. R., Barrio, A. B., & Peña, S. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.11.013
Growth Hormone Therapy in Children with Turner Syndrome, Noonan Syndrome, and SHOX Gene Mutations
Backeljauw, P. F., & Gutmark‐Little, I. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_6
Kahlert, E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7332
Dörr, H. G., Bettendorf, M., Binder, G., Brämswig, J., Hauffa, B. P., Holterhus, P., Mohnike, K. L., Schmidt, H., Stalla, G. K., Wabitsch, M., et al. (2019) · Kinder- und Jugendmedizin · doi:10.1055/a-0983-4091
Late Presentation of Turner Syndrome and Its Complications
Sani, H., & Zulkufli, N. S. (2018) · Journal of Clinical and Health Sciences · doi:10.24191/jchs.v3i2.7191
Quigley, C. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-34150-3_3
La sindrome di Turner oggi: diagnosi e terapia
Improda, N., Capalbo, D., Mase, R. D., Barbieri, F., & Salerno, M. (2012) · L Endocrinologo · doi:10.1007/bf03345982
大腸におけるインターフェロンαの産生に対する十全大補湯の作用 : MyD88、TLR4ノックアウトマウスを用いた解析
皆川, 紗., Munakata, K., & 渡辺, 賢. (2010) · 消化と吸収
Anthropometric Indices in Turner Syndrome
Kucharská, A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1788-1_100
Davenport, M. L., ROSS, J. L., & Backeljauw, P. F. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_7
Moniez, S., Pienkowski, C., & Cartault, A. (2022) · EMC - Pediatría · doi:10.1016/s1245-1789(22)46106-3
Chen, H. (2017) · Springer eBooks · doi:10.1007/978-1-4939-2401-1_238
Binder, G., & Wölfle, J. (2018) · Springer Reference Medizin · doi:10.1007/978-3-662-52794-8_23-1
Chen, H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1037-9_238
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000202323.44809.4f
General Principles of Endocrine Genetics
Polychronakos, C. (2019) · Encyclopedia of Endocrine Diseases · doi:10.1016/b978-0-12-801238-3.65741-0
Chen, H. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6430-3_238-2
Brauner, R. (2013) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(13)61652-x
Sas, T., der Velden, J. A.-V., & Keizer‐Schrama, S. M. P. F. D. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04146-5
Binder, G., & Wölfle, J. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57309-9_23
Brauner, R. (2013) · EMC - Pediatría · doi:10.1016/s1245-1789(13)65518-3
Raine, J., MBChB, J. W. G., Vliet, G. V., MB, B. J. I. W., & Deladoëy, J. (2019) · Wiley eBooks · doi:10.1002/9781119386230.ch3
Puberté normale et pathologique
Moniez, S., Pienkowski, C., & Cartault, A. (2023) · Journal de Pédiatrie et de Puériculture · doi:10.1016/j.jpp.2023.03.001 · Cited by 1
Endocrine and Growth Cases: Small Stature and Delayed Puberty
Blagowidow, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-816478-5.00057-1
Predicting the Effectiveness of Somatropin Therapy in Children with Turner Syndrome
Песковая, Н. А., & Солнцева, А. В. (2023) · Рецепт · doi:10.34883/pi.2023.26.5.009
Dantas, N. C. B. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-17052024-152537
General principles of endocrine genetics
Polychronakos, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00026-1
Growth Hormone Therapy in Children with Turner Syndrome, Noonan Syndrome, and SHOX Gene Mutations
Gutmark‐Little, I., Muthuvel, G., & Backeljauw, P. F. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_6
Abed-Alkareem, R. A., Zehhawi, D. J. A., & Alrazaq, S. A. A. (2024) · Stallion Journal for Multidisciplinary Associated Research Studies · doi:10.55544/sjmars.3.5.3
From Replacement to Tailoring: Evolving Concepts in the Therapy for Short Stature
Cianfarani, S. (2025) · Hormone Research in Paediatrics · doi:10.1159/000548478
History and Current Status of Growth Hormone Treatment in Children
Luz, C., & Collett‐Solberg, P. F. (2025) · Pediatric Drugs · doi:10.1007/s40272-025-00721-6
Alteracions neurosensorials en dones adultes amb Síndrome de Turner
Cerro, C. R. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Syndrome de Turner. Traitement par hormone de croissance
Coutant, R., Zénaty, D., & Léger, J. (2009) · Springer eBooks · doi:10.1007/978-2-287-87855-8_7
Bosmans, J., Herregods, N., van Gremberghe, I., van der Akker, E., Atapattu, N., Baronio, F., Bettendorf, M., Darendelıler, F., Deyanova, Y., Flück, C., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag092
Growth hormone therapy in Turner syndrome: Do cytogenetic subtypes influence outcomes?
Herșcovici, I.-I., Pânzaru, M.-C., Constantinescu, G., Leuștean, L., Ungureanu, M.-C., Preda, C., & Rusu, C. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endinu.2026.501821
Polak, M., & Eid, R. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.05.005
New genomic understanding and challenges in clinical care of Turner syndrome
Gravholt, C. H., Balle, C. M., Johannsen, E. B., Valsted, L. B., Hartogsohn, E. A. R., Bedei, I. A., Just, J., Backeljauw, P. F., & Stochholm, K. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00192-0
Metadata
- Authors
- Stephure, D. K.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- David K. Stephure
- ORCID
- David K. Stephure
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-06-01
- Volume
- 90
- Issue
- 6
- Pages
- 3360-3366
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2438709008
- Cited by
- 256
- References
- 25
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 13 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 15 · 2018: 11 · 2017: 8 · 2016: 15 · 2015: 13 · 2014: 12 · 2013: 15 · 2012: 19
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- Turner syndrome, growth hormone therapy, adult height, short stature, puberty induction, height gain, long-term follow-up
- MeSH terms
- Adolescent, Body Height, Female, Follow-Up Studies, Humans, Karyotyping, Phenotype, Turner Syndrome, Reproducibility of Results, Human Growth Hormone, Chromosomes, Human, Y
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
